146 related articles for article (PubMed ID: 19635373)
1. A novel LC-ESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma.
Rezk NL; White NR; Jennings SH; Kashuba AD
Talanta; 2009 Oct; 79(5):1372-8. PubMed ID: 19635373
[TBL] [Abstract][Full Text] [Related]
2. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
[TBL] [Abstract][Full Text] [Related]
3. Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
ter Heine R; Alderden-Los CG; Rosing H; Hillebrand MJ; van Gorp EC; Huitema AD; Beijnen JH
Rapid Commun Mass Spectrom; 2007; 21(15):2505-14. PubMed ID: 17610214
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a rapid ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous determination of darunavir, ritonavir, and tenofovir in human plasma: Application to human pharmacokinetics.
Reddy AV; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J; Madhavi G
J Sep Sci; 2015 Aug; 38(15):2580-7. PubMed ID: 25989063
[TBL] [Abstract][Full Text] [Related]
5. Quantification of darunavir and etravirine in human peripheral blood mononuclear cells using high performance liquid chromatography tandem mass spectrometry (LC-MS/MS), clinical application in a cohort of 110 HIV-1 infected patients and evidence of a potential drug-drug interaction.
Belkhir L; De Laveleye M; Vandercam B; Zech F; Delongie KA; Capron A; Yombi J; Vincent A; Elens L; Haufroid V
Clin Biochem; 2016 May; 49(7-8):580-6. PubMed ID: 26742721
[TBL] [Abstract][Full Text] [Related]
6. Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology.
Djerada Z; Feliu C; Tournois C; Vautier D; Binet L; Robinet A; Marty H; Gozalo C; Lamiable D; Millart H
J Pharm Biomed Anal; 2013 Dec; 86():100-11. PubMed ID: 23995753
[TBL] [Abstract][Full Text] [Related]
7. Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds.
Else L; Watson V; Tjia J; Hughes A; Siccardi M; Khoo S; Back D
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1455-65. PubMed ID: 20427248
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS determination of etravirine in rat plasma and its application in pharmacokinetic studies.
Abobo CV; Wu L; John J; Joseph MK; Bates TR; Liang D
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(30):3181-6. PubMed ID: 20965798
[TBL] [Abstract][Full Text] [Related]
9. Darunavir, ritonavir, and etravirine pharmacokinetics in the cervicovaginal fluid and blood plasma of HIV-infected women.
Patterson K; Jennings S; Falcon R; Mrus J; Kashuba A
Antimicrob Agents Chemother; 2011 Mar; 55(3):1120-2. PubMed ID: 21173188
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of the determination of plasma concentrations of darunavir, etravirine, raltegravir and ritonavir in dried blood spot samples.
Ter Heine R; Mulder JW; van Gorp EC; Wagenaar JF; Beijnen JH; Huitema AD
Bioanalysis; 2011 May; 3(10):1093-7. PubMed ID: 21585304
[TBL] [Abstract][Full Text] [Related]
11. Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine).
Arribas JR
Curr Opin HIV AIDS; 2009 Nov; 4(6):507-12. PubMed ID: 20048718
[TBL] [Abstract][Full Text] [Related]
12. Rapid, simultaneous determination of lopinavir and ritonavir in human plasma by stacking protein precipitations and salting-out assisted liquid/liquid extraction, and ultrafast LC-MS/MS.
Myasein F; Kim E; Zhang J; Wu H; El-Shourbagy TA
Anal Chim Acta; 2009 Sep; 651(1):112-6. PubMed ID: 19733744
[TBL] [Abstract][Full Text] [Related]
13. Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Crommentuyn KM; Rosing H; Nan-Offeringa LG; Hillebrand MJ; Huitema AD; Beijnen JH
J Mass Spectrom; 2003 Feb; 38(2):157-66. PubMed ID: 12577282
[TBL] [Abstract][Full Text] [Related]
14. Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry.
Ter Heine R; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
J Pharm Biomed Anal; 2009 Feb; 49(2):393-400. PubMed ID: 19059744
[TBL] [Abstract][Full Text] [Related]
15. Validation of simultaneous quantitative method of HIV protease inhibitors atazanavir, darunavir and ritonavir in human plasma by UPLC-MS/MS.
Mishra T; Shrivastav PS
ScientificWorldJournal; 2014; 2014():482693. PubMed ID: 24587725
[TBL] [Abstract][Full Text] [Related]
16. Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.
Villani P; Feroggio M; Gianelli L; Bartoli A; Montagna M; Maserati R; Regazzi MB
Ther Drug Monit; 2001 Aug; 23(4):380-8. PubMed ID: 11477320
[TBL] [Abstract][Full Text] [Related]
17. Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients.
Ter Heine R; Mulder JW; van Gorp EC; Wagenaar JF; Beijnen JH; Huitema AD
Br J Clin Pharmacol; 2010 May; 69(5):475-83. PubMed ID: 20573083
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
[TBL] [Abstract][Full Text] [Related]
19. High performance liquid chromatography using UV detection for the simultaneous quantification of the new non-nucleoside reverse transcriptase inhibitor etravirine (TMC-125), and 4 protease inhibitors in human plasma.
Hirano A; Takahashi M; Kinoshita E; Shibata M; Nomura T; Yokomaku Y; Hamaguchi M; Sugiura W
Biol Pharm Bull; 2010; 33(8):1426-9. PubMed ID: 20686242
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
Sarasa-Nacenta M; López-Púa Y; Mallolas J; Blanco JL; Gatell JM; Carné X
J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):325-32. PubMed ID: 11417878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
